Mei Yan Li

Title: Mei Yan Li - Innovator in Albumin Purification

Introduction

Mei Yan Li is a prominent inventor based in Shijiazhuang, China. She has made significant contributions to the field of biochemistry, particularly in the purification of recombinant human serum albumin (rHSA). Her innovative methods have the potential to enhance efficiency in biopharmaceutical production.

Latest Patents

Mei Yan Li holds a patent for a method of purifying recombinant human serum albumin. This method involves subjecting a cell culture supernatant to cation exchange on a bimodal high salt tolerant matrix, followed by hydrophobic interaction chromatography and anion exchange. The process allows for the recovery of purified rHSA without the need for further dilution of the cell culture supernatant. The use of a bimodal high salt tolerant cation exchange matrix not only simplifies the purification process but also reduces operational costs by requiring a smaller amount of matrix compared to conventional methods. She has 1 patent to her name.

Career Highlights

Mei Yan Li is currently employed at GE Healthcare Bio-Sciences AB, where she continues to develop innovative solutions in the field of biopharmaceuticals. Her work has been instrumental in advancing purification techniques that are crucial for the production of therapeutic proteins.

Collaborations

Throughout her career, Mei Yan Li has collaborated with notable colleagues, including Makonnen Belew and Wei Zhang. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Mei Yan Li's contributions to the field of albumin purification exemplify her dedication to advancing biopharmaceutical technologies. Her innovative methods not only improve efficiency but also reduce costs, making a significant impact in the industry.